US SB1280 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on April 25 2023 - 25% progression
Action: 2023-12-13 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 286.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on April 25 2023 - 25% progression
Action: 2023-12-13 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 286.
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to require coordinated National Institute of Standards and Technology science and research activities regarding illicit drugs containing xylazine, novel synthetic opioids, and other substances of concern, and for other purposes.
Title
TRANQ Research Act of 2023 Testing, Rapid Analysis, and Narcotic Quality Research Act of 2023
Sponsors
| Sen. Ted Cruz [R-TX] | Sen. Peter Welch [D-VT] | Sen. Shelley Capito [R-WV] | Sen. Raphael Warnock [D-GA] |
| Sen. Marsha Blackburn [R-TN] | Sen. Maria Cantwell [D-WA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-12-13 | Senate | Placed on Senate Legislative Calendar under General Orders. Calendar No. 286. |
| 2023-12-13 | Senate | Committee on Commerce, Science, and Transportation. Reported by Senator Cantwell with an amendment in the nature of a substitute. Without written report. |
| 2023-05-10 | Senate | Committee on Commerce, Science, and Transportation. Ordered to be reported with an amendment in the nature of a substitute favorably. |
| 2023-04-25 | Senate | Read twice and referred to the Committee on Commerce, Science, and Transportation. |
Same As/Similar To
HB1734 (Related) 2023-12-19 - Became Public Law No: 118-23.
